Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with, or are suspected of having, primary or returning ovarian cancer (a type of cancer affecting the ovaries and related areas), and who are scheduled for surgery, chemotherapy, and/or immunotherapy.
- People aged 18 or older.
- People who are reasonably well and able to carry out daily activities — rated on a standard health scale as 0 (fully active) to 2 (able to care for themselves but unable to do physical work).
- People who are able to attend treatment sessions and follow-up appointments.
- People who are willing and able to give written consent to take part.
Who may not be able to join:
- People who have had another type of cancer in the past 5 years, except for certain treated skin cancers that are not melanoma.
- People who have a serious infection such as HIV, hepatitis A, hepatitis B, or hepatitis C.
- People who are currently taking medications that suppress the immune system.
- People whose physical or mental health condition, in the opinion of the trial doctors, would prevent them from completing the study or from meaningfully agreeing to take part.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Judith R Kroep, MD PhD, Leiden University Medical Center
Phone: +31715263464
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Association between the mMDSC/DC ratio in PBMCs in patients with recurrent EOC before the start of treatment and OS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.